CAMILIA ZAHER: Open Payments
NPI 1023730561 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,972 in 145 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,508 · 2025 $2,972
Food & beverage: $2,774Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $787 |
| ABBVIE INC. | 26 | $459 |
| GENZYME CORPORATION | 19 | $389 |
| Lilly USA, LLC | 13 | $196 |
| UCB, Inc. | 8 | $177 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $168 |
| Arcutis Biotherapeutics, Inc. | 15 | $157 |
| Regeneron Healthcare Solutions, Inc. | 6 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Incyte Corporation | 4 | $81 |
Products named: TREMFYA, DUPIXENT, RINVOQ, TALTZ, Bimzelx, Zoryve, SKYRIZI, SILIQ.
Industry payments across CA — which companies pay providers there.
